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The highly symmetric active site of an aspartic proteinase, endothiapepsin, binds a water molecule ideally 
situated for nucleophilic attack on a substrate peptide bond whose distortion from planarity is stabilised 
by interactions of the substrate with the extended binding cleft. The apparent electrophilicity of the catalysis 
results from this distortion. The scissile peptide bond is orientated with the carbonyl oxygen hydrogen bond- 
ing to the tip of the p-hairpin ‘flap’ which lies over the cleft. Nucleophilic attack by the bound water leads 
to a tetrahedral intermediate similar to observed complexes with hydroxyl inhibitors and stabilised by 
hydrogen bonds with the flap. 
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1. INTRODUCTION 
The aspartic proteinases are the fourth major 
class of proteolytic enzymes, distinct from the 
serine, thiol and metallo proteinases. With the ex- 
ception of the renins, all the known examples are 
optimally active at acidic pH, which led to the now 
abandoned name of acid proteinases. Crystal 
structures have been determined for the archetypal 
enzyme, porcine pepsin [l], microbial enzymes 
from Penicillium janthineilum (penicillopepsin) 
[2,3], Rhizopus chinensis (rhizopuspepsin) [4,5] 
and Endothia parasitica (endothiapepsin) [6-81, 
and the inactive zymogen of pepsin, pepsinogen 
191. Structures have also been determined for 
several complexes of aspartic proteinases with 
natural and synthetic inhibitors containing 
modified peptide bonds [5, lo- 131. 
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Any mechanistic model must account for several 
biochemical phenomena observed in catalysis by 
these enzymes, particularly the marked variation in 
catalytic rate (k,& observed for substrates of dif- 
fering length and composition, compared with the 
lack of variation in the corresponding K, values 
shown for the same substrates [14,15]. Here, we 
present a comprehensive catalytic mechanism for 
the aspartic proteinases, based upon the 
crystallographic structure of endothiapepsin, 
which can explain the majority of the biochemical 
data. 
2. EXPERIMENTAL 
The crystal structure of endothiapepsin was 
refined by restrained least-squares and difference 
Fourier techniques, to an R factor of 0.16 at 2.1 A 
resolution [7,8]. The full amino acid sequence has 
been chemically determined and aligned with the 
electron density. In addition, 345 solvent 
molecules with reasonable temperature factors 
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Fig. 1. Stereo pair showing overall structure of endothiapepsin, viewed along the substrate-binding cleft. The catalytic 
aspartates 32 and 215 lie in the base of the cleft, with the flap containing Tyr 75 lying over the cleft. 
have been located. Details of the structure solution 
and refinement, will be presented elsewhere. 
3. ROLE OF THE ACTIVE-SITE BOUND 
WATER 
The highly symmetric structure of the active site 
of endothiapepsin has already been described [161. 
A clear solvent peak, seen in the refined electron 
density maps of both endothiapepsin (fig.2) and 
penicillopepsin [3], has been interpreted as a water 
molecule, polarised by hydrogen bonding interac- 
tions with the carboxyl side chains of aspartates 32 
and 215. A water molecule in this situation would 
be a powerful nucleophile. 
Earlier mechanisms [17-191 have assumed an 
electrophilic rate-limiting step, based on the obser- 
vation that aspartic proteinases, in common with 
known electrophilic systems such as H+ and car- 
boxypeptidase A, catalyse hydrolysis of esters and 
peptides at comparable rates, whereas nucleophilic 
systems, such as chymotrypsin and OH-, 
hydrolyse esters much more readily than peptides. 
Paradoxically, no significant deuterium isotope ef- 
fect is observed 1201. Distortion of the scissile pep- 
tide bond has been suggested as the means by 
which the rate-limiting step is effected by binding 
of substrate residues distant from that bond [21]. 
This distortion would reduce the double bond 
character in the C-N bond and polarise the car- 
Fig.2. Crystallographic electron density for the active-site aspartate residues 32 and 215, and the bound water molecule. 
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bonyl, making it electronically similar to an ester, 
and consequently similar in susceptibility to a rate- 
limiting nucleophilic attack by the bound water. 
Such a process would appear electrophilic by the 
criterion described above, but involves no transfer 
of electrophilic protons and would display no 
deuterium isotope effects. 
4. ORIENTATION OF THE SCISSILE 
PEPTIDE 
Structures of enzyme-inhibitor complexes 
[5,10-131 show the N-terminal side of the peptide 
inhibitor binding in an extended conformation in 
the substrate-binding cleft, with its main chain 
o _,,.....   HA0 
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Fig.3. (a) Nucleophilic attack by a polarised water 
molecule on the carbonyl carbon of the scissile peptide 
bond. The carbonyl oxygen forms a hydrogen bond (or 
possibly bonds), with a main chain peptide nitrogen at 
the bend of the flap. The parentheses around the 
hydrogen between the carboxyl groups of aspartates 32 
and 215 are to emphasise the delocalised nature of the 
hydrogen in this bond. (b) Tetrahedral transition state 
resulting from step (a). The hydroxyl group deriving 
from the nucleophilic water occupies a similar position 
to the hydroxyl groups observed in complexes with 
several hydroxy-isostere inhibitors [ 11,131. (c) Products 
of the collapse of the transition state shown in step (b). 
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forming several &sheet hydrogen bonds with 
residues in the enzyme. In particular, the NH 
groups of the peptide bonds on either side of the 
scissile pepfide hydrogen bond to the carbonyl ox- 
ygens of Gly 34 and Gly 217 in the base of the cleft, 
while the carbonyl oxygens of these inhibitor 
residues form hydrogen bonds with the NH groups 
of Gly 76 and Asp 77 which form the flexible tip 
of the p-hairpin ‘flap’ overlying the binding cleft. 
If the scissile carbonyl (absent in the inhibitors) 
were orientated with its oxygen towards the flap, it 
would also receive favourable hydrogen bonding 
interactions from the peptide NH groups of flap 
residues 76 and possibly 77. In this orientation, the 
electrostatic dipole of the scissile peptide would be 
aligned favourably, with its negative end directed 
towards the S+ peptide NH groups at the tip of the 
flap, and its 6+ carbonyl carbon directed towards 
the nucleophilic water bound by the aspartate pair. 
5. CATALYTIC MECHANISM 
Initial rate-limiting attack by the bound water 
(fig.3a) leads to an oxyanion tetrahedral in- 
termediate (fig.3b) with the original water retain- 
ing its interaction with the aspartates. The 
analogous arrangement is seen in several inhibitor 
complexes where a secondary alcohol function 
replaces the scissile peptide [ 11,131. Protonation of
the scissile peptide NH occurs after the rate- 
limiting step, and may be concomitant with col- 
lapse of the intermediate. The oxyanion could be 
stabilised by hydrogen bonds with the peptide NH 
of residue 76 and possibly of residue 77, in a man- 
ner analogous to that proposed for serine pro- 
teinases [22], with minor contributions from the 
dipole of the helix formed by residues 304-310, 
whose S+ end is directed towards the active site. 
Hydrogen bonds from the flap to the charged ox- 
ygen may serve to orientate the orbitals so that 
there is a lone pair antiperiplanar to the C-N bond 
but not to the hydroxyl C-O bond, thereby ensur- 
ing that on collapse of the tetrahedral in- 
termediate, the leaving group is the free amine 
rather than the original nucleophile [23]. 
Pyrimidalisation of the peptide nitrogen may be 
favoured by the binding-induced peptide rotation, 
which would direct the free lone pair generally 
towards the catalytic groups, and consequently no 
inversion of the lone pair and proton directions 
would be required for protonation of the NH leav- 
ing group, in contrast to that suggested for the 
serine proteinases [24]. Release of the neutral 
products, and binding of a new water molecule, 
restores the enzyme. 
6. CONCLUSION 
The mechanism described above accounts for 
much of the hitherto unexplained phenomena sur- 
rounding these enzymes, and utilises the available 
structural data without invoking any as yet 
unobserved phenomena such as the charge relays 
and large conformational changes required by 
other mechanistic models current in the literature. 
The critical assertions of peptide distortion and the 
orientation of the carbonyl bond place theoretical 
restrictions on the conformation of the substrate in 
enzyme-substrate complexes, that may be testable 
by structural studies of enzyme-inhibitor com- 
plexes. Detailed analysis of the conformational 
parameters required by this mechanism will be 
presented elsewhere. A precise identification of the 
nature of the solvent peak must await a neutron 
diffraction study. 
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